CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 195 filers reported holding CYTOKINETICS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,871,004 | -10.1% | 267,176 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $8,759,645 | -7.3% | 268,536 | +0.0% | 0.00% | 0.0% |
| Q1 2023 | $9,448,726 | -22.7% | 268,506 | +0.7% | 0.00% | -40.0% |
| Q4 2022 | $12,215,566 | -2.9% | 266,599 | +2.7% | 0.01% | 0.0% |
| Q3 2022 | $12,574,000 | +31.5% | 259,510 | +6.7% | 0.01% | +66.7% |
| Q2 2022 | $9,560,000 | +8.5% | 243,300 | +1.6% | 0.00% | 0.0% |
| Q1 2022 | $8,811,000 | -5.0% | 239,355 | +17.6% | 0.00% | 0.0% |
| Q4 2021 | $9,279,000 | +33.4% | 203,587 | +4.7% | 0.00% | +50.0% |
| Q3 2021 | $6,954,000 | +125.6% | 194,449 | +24.8% | 0.00% | +100.0% |
| Q2 2021 | $3,083,000 | -34.4% | 155,860 | -22.8% | 0.00% | -50.0% |
| Q1 2021 | $4,697,000 | +12.7% | 201,926 | +0.7% | 0.00% | 0.0% |
| Q4 2020 | $4,166,000 | -3.7% | 200,498 | +0.4% | 0.00% | 0.0% |
| Q3 2020 | $4,324,000 | +9.0% | 199,744 | +18.7% | 0.00% | 0.0% |
| Q2 2020 | $3,966,000 | +125.3% | 168,255 | +12.7% | 0.00% | +100.0% |
| Q1 2020 | $1,760,000 | +11.7% | 149,358 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $1,575,000 | +1.1% | 148,477 | +8.5% | 0.00% | 0.0% |
| Q3 2019 | $1,558,000 | +2.4% | 136,880 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $1,521,000 | +47.8% | 135,191 | +6.2% | 0.00% | 0.0% |
| Q1 2019 | $1,029,000 | +43.7% | 127,273 | +11.0% | 0.00% | 0.0% |
| Q4 2018 | $716,000 | -36.7% | 114,644 | -0.3% | 0.00% | 0.0% |
| Q3 2018 | $1,132,000 | +38.4% | 114,983 | +16.2% | 0.00% | 0.0% |
| Q2 2018 | $818,000 | +21.4% | 98,930 | +6.0% | 0.00% | 0.0% |
| Q1 2018 | $674,000 | -8.2% | 93,305 | +3.7% | 0.00% | 0.0% |
| Q4 2017 | $734,000 | -43.0% | 89,962 | +1.4% | 0.00% | 0.0% |
| Q3 2017 | $1,287,000 | +27.6% | 88,742 | +6.7% | 0.00% | 0.0% |
| Q2 2017 | $1,009,000 | +747.9% | 83,200 | +801.9% | 0.00% | – |
| Q1 2017 | $119,000 | +3.5% | 9,225 | -1.1% | 0.00% | – |
| Q4 2016 | $115,000 | +167.4% | 9,328 | +94.2% | 0.00% | – |
| Q3 2016 | $43,000 | -6.5% | 4,803 | 0.0% | 0.00% | – |
| Q2 2016 | $46,000 | +39.4% | 4,803 | 0.0% | 0.00% | – |
| Q1 2016 | $33,000 | -34.0% | 4,803 | 0.0% | 0.00% | – |
| Q4 2015 | $50,000 | – | 4,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |